Cantharidin exerts an antitumor effect by significantly inhibiting the invasion and metastasis of GC cells through the downregulation of CCAT1, thereby blocking PI3K/AKT pathway signaling (Song et al., 2020). The gene discussed is PIK3CA; the disease is gastric cancer.